Show simple item record

dc.contributor.authorHaugstvedt, A
dc.contributor.authorHernar, I
dc.contributor.authorStrandberg, RB
dc.contributor.authorRichards, DA
dc.contributor.authorNilsen, RM
dc.contributor.authorTell, GS
dc.contributor.authorGraue, M
dc.date.accessioned2019-03-04T11:26:05Z
dc.date.issued2019-01-17
dc.description.abstractIntroduction Although diabetes distress is found to be associated with decreased glycaemic control among adults with type 1 diabetes, the psychological and emotional impact of living with the condition is often not recognised and often under-reported in diabetes care. Therefore, regular assessment of diabetes distress is recommended. Assessment of diabetes distress using patient-reported outcome measures (PROMs) in clinical practice has the potential to enhance care for people with diabetes by identifying problems and improving patient-clinician communication. In this study protocol, we describe a pilot randomised controlled trial (RCT) aiming to test the feasibility of all components of an empowerment-based intervention using PROMs as dialogue support in clinical diabetes consultations, and to address the uncertainties associated with running a fully powered evaluation study. Methods and analysis We will undertake a two-Arm pilot RCT of an intervention using the Problem Areas In Diabetes (PAID) scale in clinical diabetes consultations in order to conclude whether a fully powered trial is appropriate and/or feasible. The study will also include qualitative indepth interviews with participants and healthcare providers. Our objectives are to (1) evaluate the recruitment procedures and attrition rates; (2) evaluate the performance of the randomisation procedure; (3) evaluate the participants' mean scores on the outcome measures before and after the intervention; (4) evaluate if the intervention consultations are acceptable and feasible; and (5) explore patients' and healthcare providers' experiences with the use of PAID as dialogue support and empowerment-based communication skills in clinical diabetes consultations. The quantitative data analysis includes descriptive statistics (frequencies, percentages, means, SD and CI). For the qualitative data, we will perform thematic analysis. Ethics and dissemination Ethical approval has been obtained from the Western Norway Regional Committee for Medical and Health Research Ethics (2017/1506/REC west). We will present the findings from the study phases at national and international conferences and submit manuscripts to peer-reviewed journals and popular science journals. Trial registration number NCT03471104; Pre-results.en_GB
dc.description.sponsorshipNorwegian Nurses Associationen_GB
dc.description.sponsorshipNorwegian Diabetes Associationen_GB
dc.description.sponsorshipWestern Norway University of Applied Sciencesen_GB
dc.identifier.citationVol. 9 (1), e024008en_GB
dc.identifier.doi10.1136/bmjopen-2018-024008
dc.identifier.urihttp://hdl.handle.net/10871/36229
dc.language.isoenen_GB
dc.publisherBMJ Publishing Groupen_GB
dc.rights© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.en_GB
dc.titleUse of patient-reported outcome measures (PROMs) in clinical diabetes consultations: Study protocol for the DiaPROM randomised controlled trial pilot studyen_GB
dc.typeArticleen_GB
dc.date.available2019-03-04T11:26:05Z
dc.descriptionThis is the final version. Available from BMJ Publishing Group via the DOI in this record.en_GB
dc.identifier.eissn2044-6055
dc.identifier.journalBMJ Openen_GB
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/en_GB
dcterms.dateAccepted2018-12-05
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2018-12-05
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-03-04T11:22:14Z
refterms.versionFCDVoR
refterms.dateFOA2019-03-04T11:26:09Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Except where otherwise noted, this item's licence is described as © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.